Reem Diab

6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial

Xavier Pivot, Gilles Romieu, Marc Debled et al. · The Lancet · 2019 · 125 citations

Breast Oncology, Oncology, Early Breast Cancer +6

Cutaneous adverse events related to <scp>COVID</scp> ‐19 vaccines: A cross‐sectional questionnaire‐based study of 867 patients

Mohammad Reza Pourani, Mohammad Shahidi‐Dadras, Mehri Salari et al. · Dermatologic Therapy · 2021 · 29 citations

Dermatology, Covid-19 Epidemiology, Vaccine Hesitancy +19

Lichen planus and lichen planopilaris flare after <scp>COVID</scp> ‐19 vaccination

Reem Diab, Farnaz Araghi, Mehdi Gheisari et al. · Dermatologic Therapy · 2021 · 25 citations · Full text

Clinical Immunology, Immunodeficiencies, Immunology +22

Validation of BP devices QardioArm&lt;sup&gt;&amp;reg;&lt;/sup&gt; in the general population and Omron M6 Comfort&lt;sup&gt;&amp;reg;&lt;/sup&gt; in type II diabetic patients according to the European Society of Hypertension International Protocol (ESH-IP)

Mirna N. Chahine, Jirar Topouchian, Parounak Zelveian et al. · Medical Devices Evidence and Research · 2017 · 18 citations · Full text

Questionable accuracy of home blood pressure measurements in the obese population &amp;ndash; Validation of the Microlife WatchBP O3&lt;sup&gt;&amp;reg;&lt;/sup&gt; and Omron RS6&lt;sup&gt;&amp;reg;&lt;/sup&gt; devices according to the European Society of Hypertension-International Protocol

Alaa Azaki, Reem Diab, Aya Harb et al. · Vascular Health and Risk Management · 2017 · 15 citations · Full text